Skip to content

Microneedling to improve the appearance of skin scars

Treatment of Atrophic Scars with Microneedling

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7t6d8z5
Enrollment
Unknown
Registered
2025-09-05
Start date
2023-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cicatrix

Interventions

This is a randomized, controlled, double-blind clinical trial with two parallel arms, including a total of 24 participants (22 women and 2 men
mean age of 39.2 years). Participants were randomly assigned (1:1) into two groups:Experimental group (n = 12): Scars treated with microneedling using the MMP® technique combined with intradermal infu

Sponsors

Centro de Pós Graduação da Faculdade Ciências Médicas de Minas Gerais
Lead Sponsor
Centro de Pós Graduação da Faculdade Ciências Médicas de Minas Gerais
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18 and 70 years.Diagnosis of atrophic scars.Patients who provide their informed consent to participate in the study.Of both sexes

Exclusion criteria

Exclusion criteria: Patients who do not wish to have their data used in the study.Patients with malignant tumors.Patients who do not wish to have their data used in the study.Pregnant and breastfeeding women.Patients who are not taking contraception and have an active sex life at the time of the study

Design outcomes

Primary

MeasureTime frame
Expected outcome: we believe that there will be a significant improvement in the scars of patients treated with the microneedling method without administering microdoses of 5-FU.;Outcome found: The study confirmed that microneedling with microinfusion of saline solution was effective in the clinical improvement of hypochromic linear atrophic scars. Significant improvement was observed in parameters such as pigmentation, brightness, contour, and erythema, with increased subcutaneous tissue thickness and dermal remodeling documented by ultrasonography and histopathology

Secondary

MeasureTime frame
Expected outcome: We expect to see an improvement in patient satisfaction, improvement in skin pigmentation and texture and in skin atrophy.;Outcome found: There was significant improvement in all clinical parameters evaluated (pigmentation, brightness, contour, erythema) in both groups. Patient satisfaction was high, and blinded evaluators also assigned more favorable scores, especially in the group treated with saline solution. Histologically, dermal remodeling was observed with reorganization of collagen and elastic fibers, increased cellularity, and partial repigmentation in both groups

Countries

Brazil

Contacts

Public ContactRaquel Campelo

Faculdade Ciências Médicas de Minas Gerais

cep@feluma.org.brFone: +55(31)32487155

Outcome results

None listed

Source: REBEC (via WHO ICTRP)